3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase 1
8
Phase 1/2
4
Phase NA
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Breast Neoplasms
387
Neoplasms
333
Prostatic Neoplasms
188
Lung Neoplasms
175
Colorectal Neoplasms
142
Motor Activity
87
Pancreatic Neoplasms
73
Uterine Cervical Neoplasms
70
Brain Neoplasms
69
Head and Neck Neoplasms
67
Carcinoma, Non-Small-Cell Lung
63
Ovarian Neoplasms
59
Rectal Neoplasms
49
Carcinoma, Hepatocellular
49
Colonic Neoplasms
46
Glioblastoma
42
Anxiety Disorders
41
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Depression
39
Neoplasm Metastasis
38
Hematologic Neoplasms
37
Melanoma
34
Glioma
34
Multiple Myeloma
33
Disease
33
Stomach Neoplasms
32
Sarcoma
31
Carcinoma, Renal Cell
30
Urinary Bladder Neoplasms
29
Pain
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Neuroendocrine
×
90 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled